Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.

Abstract:

BACKGROUND:There has been no clinically useful diagnostic or prognostic biomarker for renal cell carcinoma (RCC). Serum γ-glutamyltransferase (GGT) activity has been reported to be a prognostic marker for several types of cancer including RCC. Exosomes or small extracellular vesicles present in body fluids have potential as a biomarker. We have recently demonstrated that GGT activity on exosomes isolated from serum is useful for the differential diagnosis of prostate cancer and benign prostate hyperplasia. In this study, we aimed to examine if serum exosomal GGT activity could be a marker for RCC. METHODS:We examined GGT1 expression and GGT activity in cell lysates and exosomes from culture medium of HK-2 proximal tubule epithelial and RCC cell lines. GGT activity was measured using a fluorescent probe for GGT, γ-glutamyl hydroxymethyl rhodamine green. Serum and serum exosomal GGT activities were measured in patients with RCC. GGT1 expression in RCC tissues was evaluated by immunohistochemical staining. RESULTS:GGT1 levels in exosomes from KMRC-1, OS-RC-2 and 786-O cells were elevated compared with those from HK-2 cells. In exosomes, GGT1 expression correlated with GGT activity determined using a fluorescent probe for GGT. In RCC patients, serum exosomal GGT activity was elevated in those with advanced stages (III/IV vs. I/II, p = 0.037) and those with microvascular invasion (with vs. without, p = 0.034). Immunohistochemical analysis showed that membranous GGT1 expression was increased in RCC with microvascular invasion. Notably, preoperative serum exosomal GGT activity could predict the likelihood of having microvascular invasion diagnosed by pathological examination of surgically resected specimens. CONCLUSIONS:Our results suggest that serum exosomal GGT activity could be a clinically useful marker for advanced clinicopathological features of RCC patients, and its combined use with conventional diagnostic modalities may improve the diagnosis and treatment of patients.

journal_name

Oncology

journal_title

Oncology

authors

Horie K,Kawakami K,Fujita Y,Matsuda Y,Arai T,Suzui N,Miyazaki T,Koie T,Mizutani K,Ito M

doi

10.1159/000508688

subject

Has Abstract

pub_date

2020-01-01 00:00:00

pages

734-742

issue

10

eissn

0030-2414

issn

1423-0232

pii

000508688

journal_volume

98

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Mathematical aspects of dose-response studies in carcinogenesis--the concept of thresholds.

    abstract::Many of the previously proposed theories of carcinogenesis which relate the exposure level of a carcinogen to expected tumor response, are summarized and it is pointed out that these theories assume the existence of no threshold level. A modification of the one-hit carcinogenic model which would incorporate a threshol...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225106

    authors: Brown CC

    更新日期:1976-01-01 00:00:00

  • Fetal antigens in the precursor stages of gastric cancer.

    abstract::Gastric epithelial cells, identified in biopsy specimens from individuals with varying degrees of gastritis and cellular atypia, were classified according to morphology and reactivity with an adult tissue-absorbed rabbit antibody to 2nd trimester human fetal tissue. Sections of stomach from normal individuals and pati...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225796

    authors: Higgins PJ,Correa P,Cuello C,Lipkin M

    更新日期:1984-01-01 00:00:00

  • Synchronous Hodgkin's disease and gastric adenocarcinoma.

    abstract:BACKGROUND:Adenocarcinoma is the most frequent pathological type of stomach cancer. Hodgkin's lymphoma is a lymphoproliferative disease arising from lymphoid tissue which is characterized by Reed-Sternberg cells. Synchronous occurrence of these two malignancies has not been reported in the English literature so far. C...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000136799

    authors: Comez G,Pehlivan Y,Kalender ME,Sevinc A,Sari I,Camci C

    更新日期:2007-01-01 00:00:00

  • Birth defects in three common pediatric malignancies; Wilms' tumor, neuroblastoma and Ewing's sarcoma.

    abstract::During the period 1965-1980, 84 patients with Wilms' tumor, neuroblastoma and Ewing's sarcoma were treated at the University of Rochester Medical Center. All patients were evaluated for the presence of congenital abnormalities. Ten of 34 (29%) patients with Wilms' tumor, 3 of 32 (9%) patients with neuroblastoma, and 0...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226064

    authors: Nakissa N,Constine LS,Rubin P,Strohl R

    更新日期:1985-01-01 00:00:00

  • Ondansetron: a cost-effective advance in anti-emetic therapy.

    abstract::A cost-effectiveness analysis is one form of full economic evaluation where drug acquisition costs and the costs that are incurred as a result of using a particular treatment are assessed together with clinical efficacy. This paper reviews two such studies. One of the studies was a prospective randomised cost-effectiv...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227175

    authors: Cox F,Hirsch J

    更新日期:1993-05-01 00:00:00

  • Serrated adenoma of the colorectum undergoes a proliferation versus differentiation process: new conceptual interpretation of morphogenesis.

    abstract:OBJECTIVE:Serrated adenoma (SA) consists of glands both with intraluminal projection of tall columnar cells, which resemble the terminally differentiated cells in the surface epithelium, and with concave short cells, which resemble progenitor crypt cells of the colon. The aim of this study was to clarify the relationsh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151359

    authors: Jiao YF,Nakamura S,Sugai T,Yamada N,Habano W

    更新日期:2008-01-01 00:00:00

  • Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.

    abstract::Oxaliplatin-based chemotherapy is an effective first-line treatment option for patients with metastatic colorectal cancer (mCRC), which, in combination with targeted therapies and a sequential treatment approach using all active agents, has extended median overall survival to 2 years and beyond. Prolonged survival bri...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000323491

    authors: Grothey A

    更新日期:2010-01-01 00:00:00

  • Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer.

    abstract:BACKGROUND:Bevacizumab (Avastin) significantly improves overall survival (OS) and progression-free survival (PFS) when combined with first-line irinotecan (IFL) plus bolus 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic colorectal cancer (CRC). This open-label, phase IV trial evaluated the efficac...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000229787

    authors: Sobrero A,Ackland S,Clarke S,Perez-Carrión R,Chiara S,Gapski J,Mainwaring P,Langer B,Young S,AVIRI Trial investigators.

    更新日期:2009-01-01 00:00:00

  • Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.

    abstract::We examined the expression of p16, the CDKN2A gene product, in EBV-associated gastric carcinomas (EBV-GCs). EBV-GCs were identified by detecting EBV-encoded small RNA (EBER) using an in situ hybridization assay of paraffin-embedded tissue. Two non-EBV-GC cases for each EBV-GC case were selected, matched for age, sex, ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000080290

    authors: Koriyama C,Kitajima S,Nomoto M,Sueyoshi K,Itoh T,Eizuru Y,Yonezawa S,Akiba S

    更新日期:2004-01-01 00:00:00

  • Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients.

    abstract:OBJECTIVE:The pretreatment neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) have been reported to be useful as markers for prognostic factors and metastasis in several cancers. The aim of this study was to identify the predictor of lymph node (LN) metastasis by pretreatment NLR and PLR in...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000497184

    authors: Aoyama T,Takano M,Miyamoto M,Yoshikawa T,Kato K,Sakamoto T,Takasaki K,Matsuura H,Soyama H,Hirata J,Suzuki A,Sasa H,Tsuda H,Furuya K

    更新日期:2019-01-01 00:00:00

  • Therapeutic management of stage I-II high-grade primary gastric lymphomas.

    abstract::The best treatment for primary gastric lymphomas (PGL) has not yet been defined. Eighty-three patients with stage I/II PGL are documented, focusing on prognostic factors, treatment-related morbidity and mortality, and therapeutic outcome. Chemotherapy improved survival in comparison to local treatments, i.e. gastrecto...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011978

    authors: Ferreri AJ,Cordio S,Paro S,Ponzoni M,Freschi M,Veglia F,Villa E

    更新日期:1999-01-01 00:00:00

  • Performance of the mucinous-like carcinoma-associated antigen in serous effusions.

    abstract::The mucinous-like carcinoma-associated antigen (MCA), a new tumour marker, was dosed in 150 serous effusions. The levels of MCA were measured by means of an enzyme immunoassay (EIA). Ninety-seven were pleural effusions, 49 were peritoneal effusions and 4 were pericardial effusions. Thirty-five effusions were caused by...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227072

    authors: Cappellari A,Bagarella M,Olivati S,Corradi G

    更新日期:1992-01-01 00:00:00

  • Pilot study of PCNU and cranial radiation therapy in the treatment of patients with malignant gliomas.

    abstract::A pilot study was performed administering PCNU with radiation therapy to treat patients with high-grade astrocytomas and to explore the toxic effects of this drug regimen. PCNU at an initial dose of 110 mg/m2 i.v. was administered to 14 patients within 4 weeks after completion of cranial irradiation. Courses were repe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226854

    authors: Feun LG,Maor M,Stewart DJ,Leavens ME,Savaraj N,Bodey GP

    更新日期:1990-01-01 00:00:00

  • Platelet-mimicry of cancer cells: epiphenomenon with clinical significance.

    abstract::Stem cell mimicry of cancer cells has been known for a long time and is considered to be responsible for ectopic gene expressions. The stem cell characteristics of tumor cells are shown to be involved in epithelial-mesenchymal transition and in the phenomenon of vascular mimicry. Certain cancer types acquire a geno-ph...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000088069

    authors: Tímár J,Tóvári J,Rásó E,Mészáros L,Bereczky B,Lapis K

    更新日期:2005-01-01 00:00:00

  • Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results.

    abstract::Lonidamine alone or in combination with hyperthermic perfusion, with or without melphalan, was investigated in 12 patients with stage II, III, and IV malignant melanoma. The authors evaluated the most effective methods and sequence of Lonidamine administration. Preliminary results suggest that the highest effectivenes...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225899

    authors: Cavaliere R,Di Filippo F,Varanese A,Carlini S,Calabro A,Aloe L,Piarulli L

    更新日期:1984-01-01 00:00:00

  • Clinical experience with hyperthermia in conjunction with radiation therapy.

    abstract::The authors have reviewed the medical records of 421 sessions of hyperthermia treatments in 73 patients treated between 1987 and 1992 at the University Heights Cancer Center and the Indiana University Medical Center in Indianapolis, Ind. Temperatures attained during the course of therapy on each patient have been aver...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000227209

    authors: Shidnia H,Hornback N,Ford G,Shen RN

    更新日期:1993-09-01 00:00:00

  • Identification of Predictors of Recurrence in Patients with Lower Rectal Cancer Undergoing Neoadjuvant Chemotherapy: A Direct Comparison of Short-Course and Long-Course Chemoradiotherapy.

    abstract:OBJECTIVE:This study aimed to investigate clinicopathological responses and oncological outcome in patients receiving short- or long-course chemoradiotherapy (CRT) and to assess the predictive factor for recurrence in each treatment. METHODS:A total of 118 rectal cancer patients receiving preoperative CRT were enrolle...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492617

    authors: Yamamoto A,Toiyama Y,Okugawa Y,Saigusa S,Ide S,Fujikawa H,Hiro J,Yasuda H,Yoshiyama S,Ohi M,Araki T,Kusunoki M

    更新日期:2019-01-01 00:00:00

  • Human Telomerase Reverse Transcriptase Gene Promoter Mutation in Serum of Patients with Hepatocellular Carcinoma.

    abstract:BACKGROUND:Mutations in the human telomerase reverse transcriptase (hTERT) gene promoter have been reported in hepatocellular carcinoma (HCC); however, analyses of these mutations in liquid biopsies have been technically difficult because of the high GC content of the regions of interest within this promoter. We evalua...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000506135

    authors: Ako S,Nouso K,Kinugasa H,Matsushita H,Terasawa H,Adachi T,Wada N,Takeuchi Y,Mandai M,Onishi H,Ikeda F,Shiraha H,Takaki A,Fujioka S,Mimura T,Okada H

    更新日期:2020-01-01 00:00:00

  • Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging.

    abstract::Two randomized controlled trials identified that transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) shows a significant survival benefit compared with controls, after a long-term controversy. Thus, TACE is the current standard of care for patients presenting with multinodular HCC. Monit...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000345891

    authors: Minami Y,Kudo M

    更新日期:2013-01-01 00:00:00

  • Soluble tumor-associated markers in lung cancer extracts.

    abstract::Three lung tumor-associated markers (LTAM), previously identified as a Cohn Fraction IV alpha-globulin (LTAM-1), ferritin (LTAM-2) and lactoferrin (LTAM-3) were separated by a combination of ion exchange, dye-affinity and molecular sieve chromatography. They were further purified by polyacrylamide gel electrophoresis ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225542

    authors: Maxim PE,Veltri RW,Sprinkle PM

    更新日期:1981-01-01 00:00:00

  • Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.

    abstract::Abundant expression of thymidine phosphorylase (TP) mRNA and protein was observed in human carcinoma tissues relative to the corresponding normal tissues. However, the distribution of cells that express TP has not yet been determined. In this study, we examined enzyme activity of TP in 24 primary colorectal carcinoma ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000065064

    authors: Mimori K,Matsuyama A,Yoshinaga K,Yamashita K,Masuda T,Inoue H,Ueo H,Mori M

    更新日期:2002-01-01 00:00:00

  • Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification.

    abstract:OBJECTIVE:In order to improve the prognosis of pancreatic cancer patients, it is crucial to explore novel tools for its early diagnosis. Here, we attempted to screen serum biomarkers to distinguish pancreatic cancer from non-cancer individuals. METHODS:47 serum samples from pancreatic cancer patients, 39 of whom had s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000084824

    authors: Yu Y,Chen S,Wang LS,Chen WL,Guo WJ,Yan H,Zhang WH,Peng CH,Zhang SD,Li HW,Chen GQ

    更新日期:2005-01-01 00:00:00

  • Complete response of advanced hepatocellular carcinoma with multiple lung metastases treated with sorafenib: a case report.

    abstract::Sorafenib, an oral multikinase inhibitor, has demonstrated clinical efficacy in patients with advanced hepatocellular carcinoma (HCC). However, in the SHARP trial (Sorafenib HCC Assessment Randomized Protocol trial) and the Asia-Pacific trial (conducted in the Asia-Pacific region), no cases of complete response (CR) w...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000333279

    authors: Inuzuka T,Nishikawa H,Sekikawa A,Takeda H,Henmi S,Sakamoto A,Saito S,Kita R,Kimura T,Osaki Y,Kudo M

    更新日期:2011-01-01 00:00:00

  • Effect of canthaxanthin on chemically induced mammary carcinogenesis.

    abstract::Canthaxanthin, a carotenoid with no vitamin A activity, was evaluated for its efficacy in the prevention of chemically induced mammary cancers. Canthaxanthin was administered in the diet at two dose levels (3,390 or 1,130 mg/kg diet). In the dimethylbenzanthracene-induced mammary cancer model, diet supplementation wit...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226935

    authors: Grubbs CJ,Eto I,Juliana MM,Whitaker LM

    更新日期:1991-01-01 00:00:00

  • Ifosfamide in the treatment of malignant epithelial ovarian tumors.

    abstract::Ifosfamide is one of the best-known alkylating agents. In advanced epithelial ovarian cancer, it has been tested in association with cisplatin, achieving results equal, if not better than cyclophosphamide, with acceptable toxicity. In second-line therapy, it shows remarkable activity, even in patients refractory to ci...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000073361

    authors: Lissoni AA,Fei F,Rossi R,Fruscio R,Villa A,Zani G

    更新日期:2003-01-01 00:00:00

  • Cells from normal and malignant human colon mucosa differentially inhibit embryonic cell aggregation.

    abstract::A model system for studying some aspects of the interaction of cancer cells in tumors and their surrounding nonmalignant tissue is the co-culture of cancer cells and embryonic chick neural retinal cells in gyratory shakers. Neural retina cell aggregation, under these conditions, has been shown to be differentially inh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225573

    authors: Maslow DE,Mayhew E,Mittleman A

    更新日期:1981-01-01 00:00:00

  • Phase II evaluation of Ly156758 in metastatic breast cancer.

    abstract::Fourteen patients with disseminated breast cancer with primary or secondary resistance to tamoxifen were treated with LY156758. There were no complete or partial responses and 1 patient showed a minor response. These data illustrate that LY156758 did not have significant antitumor activity in patients previously treat...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226637

    authors: Buzdar AU,Marcus C,Holmes F,Hug V,Hortobagyi G

    更新日期:1988-01-01 00:00:00

  • Studies on the standardization of mistletoe preparations.

    abstract::The newly isolated phenylpropanoids syringin, syringenin-apiosylglucoside, eleutheroside E and the high molecular lectins and viscotoxins were selected for a standardization of mistletoe extracts and drug preparation. The phenylpropanoids found in all alcoholic and aqueous extracts were suitable for an HPLC fingerprin...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226416

    authors: Wagner H,Jordan E,Feil B

    更新日期:1986-01-01 00:00:00

  • A phase II trial of vindesine in hepatocellular cancer.

    abstract::Sixteen patients with histologically confirmed inoperable hepatocellular carcinoma were treated with vindesine 3 mg/m2 i.v. weekly. Anemia, leukopenia and neuritis were documented but no severe or life-threatening toxicity was seen. There were no objective responses among the 14 evaluable patients. Eight had a no chan...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227434

    authors: Falkson G,Burger W

    更新日期:1995-01-01 00:00:00

  • Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice.

    abstract::Nucleophosmin/B23 is a nucleolar phosphoprotein which redistributes from nucleoli to nucleoplasm (B23-translocation) when cells are exposed to certain anticancer drugs, particularly intercalators. The B23-translocation assay has been demonstrated in cell culture to correlate with drug effects and to detect drug-resist...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227043

    authors: Finch RA,Chan PK

    更新日期:1992-01-01 00:00:00